These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20399477)

  • 1. [The five-word test in three age-groups of mild Alzheimer's disease (60, 70 and 80 year-old patients): Utility of the Total Score, Total Weighted Score, Learning Score and Memory Score].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Rev Neurol (Paris); 2010; 166(8-9):711-20. PubMed ID: 20399477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and test-retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer's disease.
    Thompson TA; Wilson PH; Snyder PJ; Pietrzak RH; Darby D; Maruff P; Buschke H
    Arch Clin Neuropsychol; 2011 Aug; 26(5):412-24. PubMed ID: 21613302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 5-word test in 37 depressed patients compared with 36 normal controls and 35 patients with mild Alzheimer's disease].
    Croisile B; Astier JL; Beaumont C; Mollion H
    Encephale; 2011 Apr; 37(2):127-32. PubMed ID: 21482230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verbal cued recall as a predictor of conversion to Alzheimer's disease in Mild Cognitive Impairment.
    Dierckx E; Engelborghs S; De Raedt R; Van Buggenhout M; De Deyn PP; Verté D; Ponjaert-Kristoffersen I
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1094-100. PubMed ID: 19280679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Semantic Object Retrieval Test (SORT) in normal aging and Alzheimer disease.
    Kraut MA; Cherry B; Pitcock JA; Vestal L; Henderson VW; Hart J
    Cogn Behav Neurol; 2006 Dec; 19(4):177-84. PubMed ID: 17159612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?
    Balthazar ML; Cendes F; Damasceno BP
    Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The California Verbal Learning Test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia.
    Lekeu F; Magis D; Marique P; Delbeuck X; Bechet S; Guillaume B; Adam S; Petermans J; Moonen G; Salmon E
    J Clin Exp Neuropsychol; 2010 Feb; 32(2):164-73. PubMed ID: 19459119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the five-word test for the evaluation of verbal episodic memory and dementia in a memory clinic setting.
    Mormont E; Jamart J; Robaye L
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):78-84. PubMed ID: 22689699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cognitive impairment and the Rey auditory-verbal learning test in a population with Alzheimer disease.
    Barzotti T; Gargiulo A; Marotta MG; Tedeschi G; Zannino G; Guglielmi S; Dell'Armi A; Ettorre E; Marigliano V
    Arch Gerontol Geriatr Suppl; 2004; (9):57-62. PubMed ID: 15207397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the Memory Performance Index: reducing measurement error in recall tests.
    Shankle WR; Mangrola T; Chan T; Hara J
    Alzheimers Dement; 2009 Jul; 5(4):295-306. PubMed ID: 19560100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease.
    Kaltreider LB; Cicerello AR; Lacritz LH; Honig LS; Rosenberg RN; Cullum MC
    Clin Neuropsychol; 2000 Aug; 14(3):269-74. PubMed ID: 11262701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Semantic Object Retrieval Test (SORT) in amnestic mild cognitive impairment.
    Kraut MA; Cherry B; Pitcock JA; Anand R; Li J; Vestal L; Henderson VW; Hart J
    Cogn Behav Neurol; 2007 Mar; 20(1):62-7. PubMed ID: 17356346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verbal learning in Alzheimer's disease: cumulative word knowledge gains across learning trials.
    Foster PS; Drago V; Crucian GP; Rhodes RD; Shenal BV; Heilman KM
    J Int Neuropsychol Soc; 2009 Sep; 15(5):730-9. PubMed ID: 19691869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
    Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
    Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.